Rifampin is a broad-spectrum antibiotic widely used as an antitubercular drug which inhibits bacterial DNA-dependent RNA polymerase (9, 11) and is capable of diffusing into human cells (9) . Rifampin has also been described as an immunosuppressive agent particularly for delayed-type hypersensitivity and the production of antibodies in rabbits and guinea pigs (4) .
Levamisole, a potent antihelminthic agent, has been shown to stimulate granulocyte chemotaxis in vitro, restore leukocyte function in patients with decreased host defenses, and increase polymorphonuclear leukocyte killing capacity (14) . The mechanism of action of levamisole as a macrophage stimulant leading to activation is not known, although an effect on plasma membrane components has been suggested (12) .
Cytoplasmic protein antigen extracted from mycobacteria, cell walls of Streptococcus group A or Escherichia coli lipopolysaccharide can induce macrophage activation (13) . The action of these agents may be mediated by components of the alternative pathway of complement or interferon (16), or they may act as direct activating agents as observed for E. coli lipopolysaccharide (13).
5'-Nucleotidase, a plasma membrane ectoenzyme, has been cited as a biochemical criterion of macrophages in an altered morphological and biochemical state of activation (5, 6, 10, 15) . A decline in macrophage 5'-nucleotidase level is associated with activation by Corynebacterium parvum and BCG (2, 10) and stimulation by sodium caseinate and thioglycollate (5).
The production of 5'-nucleotidase, which activity decreases during macrophage activation, was studied in short-term tissue cultures of alveolar, peritoneal, liver, and spleen macrophages from normal adult guinea pigs in the presence or absence of rifampin, levamisole, or cytoplasmic protein antigen extracted from Mycobacterium microti (Vole bacillus).
Macrophages from the lung, liver, spleen, and peritoneal cavity of guinea pigs (Charles River strain) weighing 250 to 500 g were harvested and isolated by plastic adherence (1). Macrophage monolayers (1.0 x 106 cells) in medium 199 (Flow Laboratories, Ayr, United Kingdom) without serum were exposed to 102 ,uM rifampin, 1 ,uM levamisole (Sigma Chemical Co., Dorset, United Kingdom), 10 ,ug of cytoplasmic protein antigen extracted from M. microti 3379 (18) for 24 h in a 5% CO2 atmosphere at 37°C. Cell viability was constantly checked by the eosin Y dye exclusion technique. DNA synthesis was determined by [3H]thymidine incorporation. Macrophage (80 to 85%) remained viable throughout the incubation period in the presence and,absence of the three agents. At appropriate intervals, cell lysates of untreated and treated macrophages, after thorough washing of the monolayers, were prepared and assayed for 5'-nucleotidase activity as previously described (1). The units of activity were expressed in counts per minute per 106 cells.
A dose-related effect of rifampin, levamisole, and cytoplasmic protein antigen extracted from M. microti on 5'-nucleotidase production by peritoneal macrophages after a 3-h exposure to these agents was observed (Fig. 1) . It is shown by other authors that at the same range of concentration, rifampin (102 to 104 ,uM) suppresses lymphocyte function (8) and delayedtype hypersensitivity (4) . Levamisole (1.0 to 102 ,uM) has been shown to increase leukocyte function in patients with decreased host defenses (14 nucleotidase production by alveolar macrophages after 24 h, but considerable inhibition of 5'-nucleotidase production in liver macrophages was noted earlier. There was some inhibition (30 to 40o) by rifampin in cultures of peritoneal and splenic macrophages. The inhibition of 5'-nucleotidase production by rifampin may be a direct inhibitory effect of the antibiotic on macrophage metabolism as shown by a reduced uptake of [3HJthymidine (Fig. 3) and is probably not associated with macrophage activation processes. Levamisole at 1 ,uM is known to induce an immunostimulatory effect on polymorphonuclear leukocytes (11) , so a possible correlation with decreased 5'-nucleotidase activity was examined. It was found that all three agents decreased 5'-nucleotidase production to various degrees (Fig. 2) . Levamisole had a slight inhibitory effect on 5'-nucleotidase production by alveolar macrophages, but exerted more inhibition of enzyme production in cultures of peritoneal and spleen macrophages, and was virtually as effective an inhibitor as cytoplasmic protein antigen and rifampin for liver macrophage 5'-nucleotidase synthesis.
Cytoplasmic protein antigen from M. microti was the most potent inhibitor of 5'-nucleotidase 1   I  I  I  I  I I-1 production for all types of macrophages, most particularly the liver 5'-nucleotidase production, within 3 h of exposure in vitro (Fig. 2) . These results correlate with previous findings on macrophage activation by endotoxin (7), lipopolysaccharide (3), bacterial extracts (16), and mycobacterial cell wall (17) .
In spite of the decline in 5'-nucleotidase production by macrophage monolayers exposed to levamisole and cytoplasmic antigen, no inhibition of [3H]thymidine incorporation was observed (Fig. 3) . This would show that while these substances were exerting their effect on plasma membrane where 5'-nucleotidase is localized (5), the overall metabolic state of the macrophages was maintained. In such a situation, the direct binding of levamisole or cytoplasmic protein antigen to macrophage plasma membrane could have induced plasma membrane internalization which resulted in the loss or degradation of 5'-nucleotidase. According to Werb and Cohn (19) , a low level of 5'-nucleotidase is a result of inactivation of the enzyme by other lysosomal enzymes during membrane internalization and phagosome-lysosome fusion during exposure to stimulating and activating agents and during phagocytosis. The decline in 5'-nucleotidase production by macrophages exposed to levamisole and cytoplasmic protein antigen may be due to various plasma membrane modifications during treatment, which are known to be associated with the early stages of macrophage stimulation or activation. The inhibitioti of 5'-nucleotidase production during exposure to rifampin could be the result of the direct action of the drug on DNA synthesis, rather than on macrophage plasma membrane components. 
